Neurological Conditions' Surge Catalyst For Market Expansion: Key Driver Transforming The Neurotechnology Market In 2025

June 24, 2025 04:38 AM PDT | By EIN Presswire
 Neurological Conditions' Surge Catalyst For Market Expansion: Key Driver Transforming The Neurotechnology Market In 2025
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The neurotechnology market size has grown rapidly in recent years. It is slated to grow from $15.38 billion in 2024 to $17.39 billion in 2025 at a compound annual growth rate CAGR of 13.1%. Prominent factors propelling the growth include increased research funding, aging population, prevalence of neurological disorders, regulatory support, and various government initiatives.

What Is The Projected Future Growth Of The Neurotechnology Market Size?
Another significant growth driver for the neurotechnology market is the rising healthcare expenditure. This refers to spending on healthcare-related goods and services within a given healthcare system or economy. It supports the growth and implementation of neurotechnology by fostering research, facilitating access to advanced equipment, promoting education and training, supporting clinical trials, ensuring regulatory oversight, and making innovative treatments more accessible to patients in need of neurological care.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=9840&type=smp

What Are The Key Drivers Propelling The Growth Of The Neurotechnology Market?
The view ahead for the neurotechnology market looks promising. The market size is expected to see progressive growth, reaching an estimated $29.8 billion in 2029 at a compound annual growth rate CAGR of 14.4%. This growth can be primarily attributed to regulatory advancements, the interplay of genomics and neurological disorders, telemedicine in neurology, adoption of precision medicine, and the development of closed-loop systems.

In addition, anticipated trends influencing the marketplace include advancements in neuroinformatics, interventions related to neuroplasticity, initiatives about brain mapping, solutions for remote monitoring, and non-invasive brain stimulation.

What Key Player Strategies Are Driving The Neurotechnology Market?
Key industry players operating in this burgeoning neurotechnology market include General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, EndoStim Inc., Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Cleveland Medical Devices Inc., Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, Advanced Bionics AG Sonova, NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neurotech International Limited, NeurotechEU, Neurotech Solutions, Neurotech Reports, Neurotech Research Development.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

What Are The Emerging Trends In The Neurotechnology Market?
A trend emerging among these top companies is the concentrated effort to develop advanced therapeutic solutions such as the endovascular brain-computer interface BCI to enhance cognitive function and restore mobility for patients with neurological impairments.

How Is The Neurotechnology Market Segmented?
In terms of market segmentation, the neurotechnology market report covers:

1 By Conditions: Cognitive Disorders, Pain Treatment, Urinary And Faecal Incontinence, Epilepsy, Parkinson's Disease, Hearing Conditions, Sleep Disorder, Depression, Other Conditions
2 By Type: Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants, Other Types
3 By End Use: Ambulatory Surgical Centers, Hospitals, Homecare Facilities, Other End Uses.

In the Conditions subsegment, cognitive disorders include Alzheimer's Disease, Attention Deficit Hyperactivity Disorder ADHD, and dementia; while pain treatment covers chronic pain, neuropathic pain, and acute pain. The Urinary and Fecal Incontinence segment incorporates overactive bladder, neurogenic bladder, and fecal incontinence management.

What Are The Regional Insights In The Neurotechnology Market?
Regionally, North America held the largest market share for neurotechnology market in 2024. Europe, however, is expected to emerge as the fastest-growing region during the forecast period.

Browse Through More Similar Reports By The Business Research Company:

Nuclear Imaging Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Electrosurgical Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

Neurosurgery Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurosurgery-devices-and-equipment-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next